Literature DB >> 1878973

Absence of expression of the FMR-1 gene in fragile X syndrome.

M Pieretti1, F P Zhang, Y H Fu, S T Warren, B A Oostra, C T Caskey, D L Nelson.   

Abstract

We previously reported the isolation of a gene (FMR-1) expressed in brain at the fragile X locus. One exon of this gene lies within an EcoRI fragment that exhibits length variation in fragile X patients. This exon also contains the CGG repeat within the CpG island hypermethylated in fragile X patients. To study the involvement of the FMR-1 gene in the fragile X syndrome, its expression was studied in lymphoblastoid cell lines and leukocytes derived from patients and normal controls. FMR-1 mRNA was absent in the majority of male fragile X patients, suggesting a close involvement of this gene in development of the syndrome. Normal individuals and carriers all show expression. The methylation status of the BssHII site at the CpG island was also studied by Southern blot analysis of DNA from patients, carriers, and controls. The minority of fragile X affected males that show expression of FMR-1 demonstrated an associated incomplete methylation of the BssHII site.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878973     DOI: 10.1016/0092-8674(91)90125-i

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  454 in total

1.  The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain.

Authors:  K B Jensen; K Musunuru; H A Lewis; S K Burley; R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  Genetic effects on human cognition: lessons from the study of mental retardation syndromes.

Authors:  P Nokelainen; J Flint
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

3.  Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome.

Authors:  Alan P Kozikowski; Sida Shen; Marta Pardo; Maurício T Tavares; Dora Szarics; Veronick Benoy; Chad A Zimprich; Zsófia Kutil; Guiping Zhang; Cyril Bařinka; Matthew B Robers; Ludo Van Den Bosch; James H Eubanks; Richard S Jope
Journal:  ACS Chem Neurosci       Date:  2018-12-14       Impact factor: 4.418

4.  An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Ryu-ichiro Hashimoto; Kristina C Backer; Flora Tassone; Randi J Hagerman; Susan M Rivera
Journal:  J Psychiatr Res       Date:  2010-05-31       Impact factor: 4.791

Review 5.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 6.  Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.

Authors:  Elizabeth M Berry-Kravis; Lothar Lindemann; Aia E Jønch; George Apostol; Mark F Bear; Randall L Carpenter; Jacqueline N Crawley; Aurore Curie; Vincent Des Portes; Farah Hossain; Fabrizio Gasparini; Baltazar Gomez-Mancilla; David Hessl; Eva Loth; Sebastian H Scharf; Paul P Wang; Florian Von Raison; Randi Hagerman; Will Spooren; Sébastien Jacquemont
Journal:  Nat Rev Drug Discov       Date:  2017-12-08       Impact factor: 84.694

7.  Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome.

Authors:  Bradford Coffee; Fuping Zhang; Stephanie Ceman; Stephen T Warren; Daniel Reines
Journal:  Am J Hum Genet       Date:  2002-09-13       Impact factor: 11.025

8.  Covariate adjusted correlation analysis with application to FMR1 premutation female carrier data.

Authors:  Damla Sentürk; Danh V Nguyen; Flora Tassone; Randi J Hagerman; Raymond J Carroll; Paul J Hagerman
Journal:  Biometrics       Date:  2009-01-23       Impact factor: 2.571

9.  The DNA replication program is altered at the FMR1 locus in fragile X embryonic stem cells.

Authors:  Jeannine Gerhardt; Mark J Tomishima; Nikica Zaninovic; Dilek Colak; Zi Yan; Qiansheng Zhan; Zev Rosenwaks; Samie R Jaffrey; Carl L Schildkraut
Journal:  Mol Cell       Date:  2013-11-27       Impact factor: 17.970

Review 10.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.